Atlas Trials

Bai-Rong Xia

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bai-Rong Xia

RecordFirmDate
An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer (NCT07667751)Bai-Rong Xia2026-06-01
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer (NCT07125391)Bai-Rong Xia2025-06-20
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer (NCT05652283)Bai-Rong Xia2022-11-06

Track Bai-Rong Xia automatically

Every clearance here is in the API, with alerts when new ones post.